4-Chloro-6,7,8-trimethoxyquinazoline → HCID 22923429, Verbindung

HRID 1451900

Reaktionsgleichung

Reaktionsgleichung von HRID 1451900
Br.[CH3:2][N:3]1[C:12]2[C:7](=[CH:8][C:9]([CH3:13])=[CH:10][CH:11]=2)[C:6](=[O:14])[N:5]([CH:15]2[CH2:20][CH2:19][NH:18][CH2:17][CH2:16]2)[C:4]1=[O:21].Cl[C:23]1[C:32]2[C:27](=[C:28]([O:37][CH3:38])[C:29]([O:35][CH3:36])=[C:30]([O:33][CH3:34])[CH:31]=2)[N:26]=[CH:25][N:24]=1>>[CH3:2][N:3]1[C:12]2[C:7](=[CH:8][C:9]([CH3:13])=[CH:10][CH:11]=2)[C:6](=[O:14])[N:5]([CH:15]2[CH2:20][CH2:19][N:18]([C:23]3[C:32]4[C:27](=[C:28]([O:37][CH3:38])[C:29]([O:35][CH3:36])=[C:30]([O:33][CH3:34])[CH:31]=4)[N:26]=[CH:25][N:24]=3)[CH2:17][CH2:16]2)[C:4]1=[O:21]

Komponenten

3

Edukt 2

HCID 1006864-Chloro-6,7,8-trimethoxyquinazolineHCID 218512221,2,3,4-Tetrahydro-1,6-dimethyl-2,4-dioxo-3-(4-piperidinyl)quinazoline hydrobromide2×

Produkt 1

HCID 22923429HCID 22923429, VerbindungAusbeute 25 %

Versuchsvorschrift

The procedure similar to that described in Example 57 was repeated, except that 1.06 g (3.0 mmol) of 1,2,3,4-tetrahydro-1,6-dimethyl-2,4-dioxo-3-(4-piperidinyl)quinazoline hydrobromide (Compound v) obtained in Example 41 was used and 4-chloro-6,7,8-trimethoxyquinazoline was used in place of 4-chloro-6,7-dimethoxyquinazoline. As a result, 365.1 mg (yield: 25%) of Compound 86 was obtained as white crystals.

Aufarbeitung

  1. customobtained in Example 41

Quellen und Nachweise

ORD-Eintrag
ord-1c08b2c553af49e19c1eefe528f3a07c
Quelldatensatz
uspto-grants-1997_02
Patentnummer
US05605900

Verknüpfte Notizen

Wird geladen…